Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Telaprevir for genotype 1 chronic hepatitis C: a systematic review and meta-analysis.

Gu L, Chen Q, Xie J, Yan Y, Wu G, Tan J, Liang B, Chen W, Wu P, Su L, Tang N.

Pharmazie. 2012 Dec;67(12):963-72. Review.

PMID:
23346756
[PubMed - indexed for MEDLINE]
2.

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.

Hauser G, Awad T, Brok J, Thorlund K, Štimac D, Mabrouk M, Gluud C, Gluud LL.

Cochrane Database Syst Rev. 2014 Feb 28;2:CD005441. Review.

PMID:
24585509
[PubMed - indexed for MEDLINE]
3.

Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.

Perry CM.

Drugs. 2012 Mar 26;72(5):619-41. doi: 10.2165/11208370-000000000-00000. Review.

PMID:
22439668
[PubMed - indexed for MEDLINE]
4.

Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.

Hartwell D, Jones J, Baxter L, Shepherd J.

Health Technol Assess. 2011 Apr;15(17):i-xii, 1-210. doi: 10.3310/hta15170. Review.

PMID:
21473834
[PubMed - indexed for MEDLINE]
Free Article
5.

Telaprevir: a hepatitis C NS3/4A protease inhibitor.

Matthews SJ, Lancaster JW.

Clin Ther. 2012 Sep;34(9):1857-82. doi: 10.1016/j.clinthera.2012.07.011. Epub 2012 Aug 28. Review.

PMID:
22951253
[PubMed - indexed for MEDLINE]
6.

Telaprevir for chronic hepatitis C with genotype 1: a meta-analysis.

Dang SS, Wang WJ, Wang XF, Li YP, Li M, Jia XL, Wang Y, Liu E, Zhao S.

Hepatogastroenterology. 2012 Mar-Apr;59(114):461-8. doi: 10.5754/hge11312. Review.

PMID:
21940388
[PubMed - indexed for MEDLINE]
7.

WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.

Gluud LL, Krogsgaard K, Gluud C.

Cochrane Database Syst Rev. 2007 Jul 18;(2):CD002234. Review.

PMID:
17636700
[PubMed - indexed for MEDLINE]
8.

Ribavirin with or without alpha interferon for chronic hepatitis C.

Kjaergard LL, Krogsgaard K, Gluud C.

Cochrane Database Syst Rev. 2002;(2):CD002234. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD002234.

PMID:
12076442
[PubMed - indexed for MEDLINE]
9.

Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.

Brok J, Gluud LL, Gluud C.

Arch Intern Med. 2005 Oct 24;165(19):2206-12. Review.

PMID:
16246984
[PubMed - indexed for MEDLINE]
10.

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.

Koretz RL, Pleguezuelo M, Arvaniti V, Barrera Baena P, Ciria R, Gurusamy KS, Davidson BR, Burroughs AK.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD003617. doi: 10.1002/14651858.CD003617.pub2. Review.

PMID:
23440791
[PubMed - indexed for MEDLINE]
11.

Ribavirin plus interferon versus interferon for chronic hepatitis C.

Brok J, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005445. doi: 10.1002/14651858.CD005445.pub2. Review.

PMID:
20091577
[PubMed - indexed for MEDLINE]
12.

Ribavirin monotherapy for chronic hepatitis C.

Brok J, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005527. doi: 10.1002/14651858.CD005527.pub2. Review.

PMID:
19821346
[PubMed - indexed for MEDLINE]
13.

Safety of telaprevir for chronic hepatitis C virus infection: a meta-analysis of randomized controlled trials.

Qin H, Li H, Zhou X, Feng F, Shen Y, Tan H, Ye F, Xie Y.

Clin Drug Investig. 2012 Oct 1;32(10):665-72. doi: 10.2165/11633240-000000000-00000. Review.

PMID:
22889114
[PubMed - indexed for MEDLINE]
14.

Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.

Kjaergard LL, Krogsgaard K, Gluud C.

Cochrane Database Syst Rev. 2002;(1):CD002234. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD002234.

PMID:
11869633
[PubMed - indexed for MEDLINE]
15.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.

PMID:
15461877
[PubMed - indexed for MEDLINE]
Free Article
16.

Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.

Iorio A, Marchesini E, Awad T, Gluud LL.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004888. doi: 10.1002/14651858.CD004888.pub2. Review.

PMID:
20091566
[PubMed - indexed for MEDLINE]
17.

Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients.

Burney T, Dusheiko G.

Expert Rev Anti Infect Ther. 2011 Feb;9(2):151-60. doi: 10.1586/eri.10.153. Epub 2010 Dec 14. Review.

PMID:
21143041
[PubMed - indexed for MEDLINE]
18.

Telaprevir: an oral protease inhibitor for hepatitis C virus infection.

Kim JJ, Culley CM, Mohammad RA.

Am J Health Syst Pharm. 2012 Jan 1;69(1):19-33. doi: 10.2146/ajhp110123. Review.

PMID:
22180548
[PubMed - indexed for MEDLINE]
19.

Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus.

Gluud LL, Marchesini E, Iorio A.

Am J Gastroenterol. 2009 Sep;104(9):2335-41; quiz 2342. doi: 10.1038/ajg.2009.311. Epub 2009 Jun 9. Review.

PMID:
19513022
[PubMed - indexed for MEDLINE]
20.

Ribavirin plus interferon versus interferon for chronic hepatitis C.

Brok J, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005445. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD005445.

PMID:
16034976
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk